Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 68382-396

4 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 68382-396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (41052ba8 E11b 444d 8e3a E2045768f7e3 01)

Figure-1 (41052ba8 E11b 444d 8e3a E2045768f7e3 01)
Chemical structure diagram showing sodium phenylacetate and sodium benzoate molecules. The image depicts the molecular formulas with labeled sodium (Na) atoms and structural components for both compounds.*
FDA Label Image

Figure-2 (41052ba8 E11b 444d 8e3a E2045768f7e3 02)

Figure-2 (41052ba8 E11b 444d 8e3a E2045768f7e3 02)
A biochemical pathway diagram illustrating the urea cycle and related metabolic processes involving benzoate and phenylacetate. Key intermediates and enzymes such as Carbamyl phosphate, Citrulline, Argininosuccinate, and Arginine are labeled, along with enzyme abbreviations like CPS, OTC, ASS, ASL, and ARG. The diagram shows connections to urine excretion and the conversion of benzoate to hippurate and phenylacetate to phenylacetylglutamine, detailing nitrogen disposal and amino acid metabolism.*
FDA Label Image

Vial-label (41052ba8 E11b 444d 8e3a E2045768f7e3 03)

Vial-label (41052ba8 E11b 444d 8e3a E2045768f7e3 03)
Label for Sodium Phenylacetate and Sodium Benzoate Injection 10% / 10%, 50 mL vial, for intravenous use only. The label includes usage warnings, dosage instructions referring to package insert, dilution requirements, storage conditions, and distributor information for Zydus Pharmaceuticals USA Inc. The label includes barcode and NDC 68382-396-01.*
FDA Label Image

Carton-label (41052ba8 E11b 444d 8e3a E2045768f7e3 04)

Carton-label (41052ba8 E11b 444d 8e3a E2045768f7e3 04)
Packaging label for Sodium Phenylacetate and Sodium Benzoate Injection 10% / 10%, 50 mL solution concentrate for intravenous use. The label includes the drug name, strength, volume, NDC 68382-396-01, Rx only status, storage instructions, and distributor information for Zydus Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.